| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 10.600 | 10.015 | 8.051 | 8.033 | 11.906 | 10.327 | 11.250 | 9.683 | 9.099 | 9.851 |
| Total Income - EUR | 10.600 | 10.015 | 8.051 | 8.033 | 11.906 | 10.327 | 11.250 | 9.683 | 9.099 | 10.275 |
| Total Expenses - EUR | 7.689 | 6.261 | 8.826 | 9.668 | 9.676 | 9.932 | 9.837 | 6.651 | 2.044 | 3.995 |
| Gross Profit/Loss - EUR | 2.911 | 3.754 | -775 | -1.636 | 2.230 | 394 | 1.413 | 3.032 | 7.055 | 6.280 |
| Net Profit/Loss - EUR | 2.593 | 3.553 | -855 | -1.716 | 2.111 | 297 | 1.300 | 2.846 | 6.095 | 5.241 |
| Employees | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 0 | 0 |
Check the financial reports for the company - Dr. Lupaşcu S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 2.976 | 3.936 | 769 | 21 | 1.547 | 915 | 2.406 | 3.229 | 9.662 | 12.275 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 2.976 | 3.936 | 768 | 21 | 1.547 | 915 | 2.406 | 3.229 | 9.662 | 12.275 |
| Shareholders Funds | 2.584 | 3.544 | 325 | -1.397 | 741 | 360 | 1.653 | 2.908 | 8.994 | 12.000 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 392 | 392 | 444 | 1.418 | 806 | 555 | 753 | 321 | 668 | 275 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr. Lupaşcu S.r.l.